Reaction
Leukocytoclastic Vasculitis reporting signals
As of the last recalculation, Leukocytoclastic Vasculitis appears in 1,629 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 23.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifampicin | 18 | 23.0 | 23.0 |
| Fondaparinux Sodium | 8 | 12.7 | 12.7 |
| Sucralfate Oral | 12 | 10.9 | 10.9 |
| Sucralfate Oral Suspension | 12 | 10.8 | 10.8 |
| Clarithromycin | 28 | 10.6 | 10.6 |
| Amoxicillin And Clavulanate Potassium | 21 | 10.0 | 10.0 |
| Warfarin Sodium | 32 | 9.0 | 9.0 |
| Metformin Hcl | 37 | 8.7 | 8.7 |
| Human Insulin | 8 | 8.2 | 8.2 |
| Isoniazid | 10 | 7.9 | 7.9 |
| Cetuximab | 18 | 7.4 | 7.4 |
| Erlotinib Hydrochloride | 7 | 7.2 | 7.2 |
| Erlotinib | 5 | 6.6 | 6.6 |
| Deferasirox | 10 | 4.8 | 4.8 |